Study will monitor weight loss and metabolic indicators for subjects in single-center, single arm trial.
Single-Center, Open-label Pilot Study to Evaluate the Safety and Effectiveness of the GI Windows Single Neodymium Magnet Anastomosis Procedure When Used to Create a Duodenal-Ileal Diversion for Subjects with Inadequate Weight Loss or Weight Regain Following Sleeve Gastrectomy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
27
The SFM will be placed using an endoscope in the duodenum and laparoscopically into the ileum. A compression anastomosis will be created in each of the subjects and the diversion of enteral flow from the duodenum to ileum will create a metabolic effect that will induce weight loss and impact metabolic disease indicators
Centro Medico Teknon
Barcelona, Spain
Weight Loss
1\. Weight loss measured as a percent of total body weight (TBW)
Time frame: 12 Months
Percent responders
Percent of subjects losing at least 10% and 20% of baseline weight from baseline
Time frame: 12 Months
Excess weight loss
Mean change in Excess weight loss from baseline
Time frame: 12 Months
Change in serum lipids
Mean change in serum lipids from baseline
Time frame: 12 Months
Change in blood pressure
Mean change in blood pressure from baseline
Time frame: 12 Months
Change in fasting glucose
Mean change in fasting glucose in subjects with T2DM at baseline
Time frame: 12 Months
Change in HbA1c
Mean change in HbA1c in subjects with T2DM at baseline
Time frame: 12 Months
Change in BMI
Mean change in BMI from baseline
Time frame: 12 Months
Change in Absolute Weight Loss
Mean change in Absolute Weight Loss from baseline
Time frame: 12 Months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.